Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yestar Healthcare Holdings CoHKSE:02393 +4.55% Market Cap is HK$161 Mil as of Sep. 21, 2026. The stock has 4 warning signs investors should review. Among 862 Medical Devices & Instruments companies, Yestar Healthcare Holdings Co ranks worse than 76.68% on this metric.
Yestar Healthcare Holdings Co's quarterly market cap
declined
from Jun. 2025 (HK$263 Mil) to Dec. 2025 (HK$235 Mil) and
declined
from Dec. 2025 (HK$235 Mil) to Jun. 2026 (HK$138 Mil).
Yestar Healthcare Holdings Co's annual market cap
increased
from Dec. 2023 (HK$105 Mil) to Dec. 2024 (HK$145 Mil) and
increased
from Dec. 2024 (HK$145 Mil) to Dec. 2025 (HK$235 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Yestar Healthcare Holdings Co's Enterprise Value for Today is HK$201 Mil.
Yestar Healthcare Holdings Co (HKSE:02393) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Yestar Healthcare Holdings Co Market Cap Related Terms
Yestar Healthcare Holdings Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02393 vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, Yestar Healthcare Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yestar Healthcare Holdings Co Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Yestar Healthcare Holdings Co's Market Cap falls into.
Yestar Healthcare Holdings Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co (HKSE:02393) has a Market Cap of HK$161 Mil as of Sep. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yestar Healthcare Holdings Co and its competitors. According to the industry distribution chart, Yestar Healthcare Holdings Co ranks #661 out of 862 companies in the Medical Devices & Instruments industry, placing it in the top 76.7%.
Is Yestar Healthcare Holdings Co's Market Cap too high?
Yestar Healthcare Holdings Co's current Market Cap is HK$161 Mil. Based on the distribution chart, Yestar Healthcare Holdings Co ranks #661 out of 862 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Yestar Healthcare Holdings Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Yestar Healthcare Holdings Co ranks #661 out of 862 companies for Market Cap. This places Yestar Healthcare Holdings Co in the lower half of its industry. The industry median Market Cap is 120.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.73, based on 862 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Yestar Healthcare Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yestar Healthcare Holdings Co's current Market Cap is HK$161 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current Market Cap is HK$161 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current Market Cap is HK$161 Mil as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02393 has been successfully added to your 
